Sanofi-aventis (Thailand) Limited
Sanofi-aventis Thailand is part of Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Sanofi has its roots registered as Hoechst in Thailand since 1959. The company today has grown organically as well as through various mergers and acquisitions; at present there are almost 450 employees.
Sanofi group in Thailand is composed of two companies:
- Sanofi-aventis (Thailand) Ltd. which addresses the pharmaceutical and consumer healthcare markets whereby the company also has its footprint in rare disease market;
- Sanofi Pasteur Ltd. which focuses on the human vaccine market. The company has established, in 1997, a joint venture company with the Government Pharmaceutical Organization (GPO) and the CPB Equity Co., Ltd., called the GPO-MBP Ltd. manufacturing vaccines for local public needs as well as for export.